Prosecution Insights
Last updated: July 17, 2026
Application No. 18/395,041

DETECTION OF AN ENDOSCOPE TO A FLUID MANAGEMENT SYSTEM

Non-Final OA §101§112
Filed
Dec 22, 2023
Priority
Jun 27, 2019 — provisional 62/867,557 +1 more
Examiner
PATEL, SHEFALI DILIP
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Boston Scientific Scimed Inc.
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
1y 3m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
431 granted / 742 resolved
-11.9% vs TC avg
Strong +27% interview lift
Without
With
+27.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
53 currently pending
Career history
805
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
82.2%
+42.2% vs TC avg
§102
9.0%
-31.0% vs TC avg
§112
6.4%
-33.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 742 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement filed March 6, 2024 (28 pages), fails to comply with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609 because: The citation for US 20120116168 has been provided with the incorrect name of patentee of Moellstam et al. The correct name of patentee for US 20120116168 is Mollstam et al. Thus, it is unclear whether Applicant is intending to cite US 20120116168 or another document to Moellstam et al It has been placed in the application file, but the information referred to therein has not been considered as to the merits. Applicant is advised that the date of any re-submission of any item of information contained in this information disclosure statement or the submission of any missing element(s) will be the date of submission for purposes of determining compliance with the requirements based on the time of filing the statement, including all certification requirements for statements under 37 CFR 1.97(e). See MPEP § 609.05(a). The information disclosure statement filed March 6, 2024 (37 pages), fails to comply with the provisions of 37 CFR 1.97, 1.98 and MPEP § 609 because: The citation for US 6843099 has been provided with the incorrect name of patentee of Daw et al. The correct name of patentee for US 6843099 is Derek et al. Thus, it is unclear whether Applicant is intending to cite US 6843099 or another document to Daw et al The citation for US 7981073 has been provided with the incorrect name of patentee of Moellstam et al. The correct name of patentee for US 7981073 is Mollstam et al. Thus, it is unclear whether Applicant is intending to cite US 7981073 or another document to Moellstam et al It has been placed in the application file, but the information referred to therein has not been considered as to the merits. Applicant is advised that the date of any re-submission of any item of information contained in this information disclosure statement or the submission of any missing element(s) will be the date of submission for purposes of determining compliance with the requirements based on the time of filing the statement, including all certification requirements for statements under 37 CFR 1.97(e). See MPEP § 609.05(a). The information disclosure statement filed March 6, 2024 (37 pages), fails to comply with 37 CFR 1.98(a)(3)(i) because it does not include a concise explanation of the relevance, as it is presently understood by the individual designated in 37 CFR 1.56(c) most knowledgeable about the content of the information, of each reference listed that is not in the English language. It has been placed in the application file, but the information referred to therein has not been considered: No English translation for understanding of JP 01087708 has been provided No English translation for understanding of JP 05293114 has been provided The information disclosure statement filed March 6, 2024 (37 pages), fails to comply with 37 CFR 1.98(a)(2), which requires a legible copy of each cited foreign patent document; each non-patent literature publication or that portion which caused it to be listed; and all other information or that portion which caused it to be listed. It has been placed in the application file, but the information referred to therein has not been considered: No copy of WO 9956639 has been provided Claim Objections Claim 10 is objected to because of the following informalities: In regards to claim 10, line 1, “wherein the wherein the” should be changed to “wherein the”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-20 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In regards to claim 1, line 3 recites “a medical device”. Claim 1, line 1 previously recites “a medical device”. It is unclear whether the two recitations are the same or different. Claims 2-8 are rejected by virtue of being dependent upon claim 1. In regards to claim 1, line 8 recites “the medical device”. Claim 1, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 1, line 8. Claims 2-8 are rejected by virtue of being dependent upon claim 1. In regards to claim 2, line 2 recites “the medical device”. Claim 2 depends upon claim 1. Claim 1, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 2, line 2. In regards to claim 5, line 2 recites “the medical device”. Claim 5 depends upon claim 1. Claim 1, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 5, line 2. Claim 6 is rejected by virtue of being dependent upon claim 5. In regards to claim 7, line 2 recites “the medical device”. Claim 7 depends upon claim 1. Claim 1, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 7, line 2. Claim 8 is rejected by virtue of being dependent upon claim 7. In regards to claim 9, line 3 recites “a medical device”. Claim 9, line 1 previously recites “a medical device”. It is unclear whether the two recitations are the same or different. Claims 10-11 are rejected by virtue of being dependent upon claim 9. In regards to claim 9, line 6 recites “a patient’s body”. Claim 9, line 1 previously recites “a body of a patient”. It is unclear whether the two recitations are the same or different. Claims 10-11 are rejected by virtue of being dependent upon claim 9. In regards to claim 9, line 9 recites “the medical device”. Claim 9, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 9, line 9. Claims 10-11 are rejected by virtue of being dependent upon claim 9. In regards to claim 12, line 3 recites “a medical device”. Claim 12, line 1 previously recites “a medical device”. It is unclear whether the two recitations are the same or different. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 3 recites “the medical device”. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 12, line 3. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 4 recites “the pump”. There is insufficient antecedent basis for this limitation in the claim. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, lines 4-5 recite “the fluid management system”. There is insufficient antecedent basis for this limitation in the claim. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 8 recites “a fluid management system”. Claim 12, lines 4-5 previously recite “the fluid management system”. It is unclear whether the two recitations are the same or different. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, lines 8-9 recite “the fluid management system”. Claim 12, lines 4-5 previously recite “the fluid management system” and line 8 previously recites “a fluid management system”. It is unclear which fluid management system is referred to in claim 12, lines 8-9. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 10 recites “a pump”. Claim 12, line 4 previously recites “the pump”. It is unclear whether the two recitations are the same or different. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, lines 10-11 recite “the fluid management system”. Claim 12, lines 4-5 previously recite “the fluid management system” and line 8 previously recites “a fluid management system”. It is unclear which fluid management system is referred to in claim 12, lines 10-11. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 13 recites “the pump”. Claim 12, line 4 previously recites “the pump” and line 10 previously recites “a pump”. It is unclear which pump is referred to in claim 12, line 13. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 12, line 17 recites “the medical device”. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 12, line 17. Claims 13-20 are rejected by virtue of being dependent upon claim 12. In regards to claim 14, line 2 recites “the pump”. Claim 14 depends upon claim 12. Claim 12, line 4 previously recites “the pump” and line 10 previously recites “a pump”. It is unclear which pump is referred to in claim 14, line 2. In regards to claim 15, line 2 recites “the medical device”. Claim 15 depends upon claim 12. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 15, line 2. In regards to claim 15, line 3 recites “the fluid management system”. Claim 15 depends upon claim 12. Claim 12, lines 4-5 previously recite “the fluid management system” and line 8 previously recites “a fluid management system”. It is unclear which fluid management system is referred to in claim 15, line 3. In regards to claim 16, line 2 recites “a distal end of the medical device”. Claim 16 depends upon claim 12. Claim 12, line 6 previously recites “a distal end of the elongate shaft”. It is unclear whether the two recitations are the same or different. In regards to claim 16, line 2 recites “the medical device”. Claim 16 depends upon claim 12. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 16, line 2. In regards to claim 17, line 2 recites “a distal end of the medical device”. Claim 17 depends upon claim 12. Claim 12, line 6 previously recites “a distal end of the elongate shaft”. It is unclear whether the two recitations are the same or different. In regards to claim 17, line 2 recites “the medical device”. Claim 17 depends upon claim 12. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 17, line 2. In regards to claim 17, line 2 recites “the fluid management system”. Claim 17 depends upon claim 12. Claim 12, lines 4-5 previously recite “the fluid management system” and line 8 previously recites “a fluid management system”. It is unclear which fluid management system is referred to in claim 17, line 2. In regards to claim 20, line 2 recites “a predetermined condition”. Claim 20 depends upon claim 12. Claim 12, line 16 previously recites “a predetermined condition”. It is unclear whether the two recitations are the same or different. In regards to claim 20, line 2 recites “the data”. First, there is insufficient antecedent basis for this limitation in the claim. Second, claim 20 depends upon claim 12. Claim 12, line 3 previously recites “a first set of data” and line 8 previously recites “a second set of data”. It is unclear whether “the data” of claim 20 refers to one of “a first set of data” or “a second set of data” of claim 12 or is different. In regards to claim 20, line 2 recites “the medical device”. Claim 20 depends upon claim 12. Claim 12, line 1 previously recites “a medical device” and line 3 previously recites “a medical device”. It is unclear which medical device is referred to in claim 20, line 2. In regards to claim 20, line 3 recites “the fluid management system”. Claim 20 depends upon claim 12. Claim 12, lines 4-5 previously recite “the fluid management system” and line 8 previously recites “a fluid management system”. It is unclear which fluid management system is referred to in claim 20, line 3. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 1 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim recites “receiving a first set of data from a medical device; receiving a second set of data from a fluid management system, the second set of data being a same type of data as the first set of data; comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient”. This judicial exception is not integrated into a practical application because the claim steps are capable of being performed in the human mind as a mental process. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception because: though the claim step “receiving a first set of data from a medical device” recites a medical device, said medical device only sends a first set of data that is capable of being received by the human mind as a mental process; though the claim step “receiving a second set of data from a fluid management system” recites a fluid management system, said fluid management system only sends a second set of data that is capable of being received by the human mind as a mental process; and the claim steps of “comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient” can all be performed by the human mind as a mental process. Thus, claim 1 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claims 2-8 are rejected by virtue of being dependent upon claim 1. Claim 9 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim recites “receiving a first set of pressure data from a medical device; receiving a second set of data at a processing device, the second set of data being a same type of data as the first set of data and representative of a pulsatile pressure generated within a patient’s body; comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient”. This judicial exception is not integrated into a practical application because the claim steps are capable of being performed in the human mind as a mental process. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception because: though the claim step “receiving a first set of pressure data from a medical device” recites a medical device, said medical device only sends a first set of data that is capable of being received by the human mind as a mental process; though the claim step “receiving a second set of data at a processing device” recites a processing device, said processing device only sends a second set of data that is capable of being received by the human mind as a mental process; and the claim steps of “comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient” can all be performed by the human mind as a mental process. Thus, claim 9 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claims 10-11 are rejected by virtue of being dependent upon claim 9. Claim 12 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim recites “receiving a first set of data from a medical device, the medical device comprising: an elongate shaft in fluid communication with the pump of the fluid management system; a pressure sensor disposed at a distal end of the elongate shaft; and a handle coupled to a proximal end of the elongate shaft; receiving a second set of data from a fluid management system, the fluid management system comprising: a pump configured to pump fluid from a fluid supply source through the fluid management system at a fluid flow rate; and a processing device including a user interface, the processing device configured to control the pump to maintain a target fluid flow rate based on a set of system operating parameters; comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient”. This judicial exception is not integrated into a practical application because the claim steps are capable of being performed in the human mind as a mental process. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception because: though the claim step “receiving a first set of data from a medical device, the medical device comprising: an elongate shaft in fluid communication with the pump of the fluid management system; a pressure sensor disposed at a distal end of the elongate shaft; and a handle coupled to a proximal end of the elongate shaft” recites a medical device, said medical device only sends a first set of data that is capable of being received by the human mind as a mental process, and the elongate shaft, the pressure sensor, and the handle of the medical device are not used in a practical application in the claim; though the claim step “receiving a second set of data from a fluid management system, the fluid management system comprising: a pump configured to pump fluid from a fluid supply source through the fluid management system at a fluid flow rate; and a processing device including a user interface, the processing device configured to control the pump to maintain a target fluid flow rate based on a set of system operating parameters” recites a fluid management system, said fluid management system only sends a second set of data that is capable of being received by the human mind as a mental process, and the pump and the processing device including a user interface of the fluid management system are not used in a practical application in the claim; and the claim steps of “comparing the first set of data with the second set of data; and if the first set of data and the second set of data meet a predetermined condition, determining the medical device is within the body of the patient” can all be performed by the human mind as a mental process. Thus, claim 12 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claims 13-20 are rejected by virtue of being dependent upon claim 12. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHEFALI D PATEL whose telephone number is (571)270-3645. The examiner can normally be reached Monday-Friday 8:30am-4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin C Sirmons can be reached at (571) 272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHEFALI D PATEL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Dec 22, 2023
Application Filed
May 29, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678561
COATED SUBCUTANEOUS DEVICE AND INSERTER SYSTEM
2y 3m to grant Granted Jul 14, 2026
Patent 12667658
CASSETTE FOR A CONSOLE OF AN OPHTHALMOSURGICAL SYSTEM, AND OPHTHALMOSURGICAL SYSTEM
3y 9m to grant Granted Jun 30, 2026
Patent 12636437
Injector device having a braking arrangement
3y 8m to grant Granted May 26, 2026
Patent 12629495
SHEATH AND CANNULA COMBINATION DEVICES FOR SELECTIVELY DIRECTING BLOOD FLOW AND ENABLING INTERVENTIONAL MEDICAL PROCEDURES
1y 1m to grant Granted May 19, 2026
Patent 12623023
Drug Delivery Device and Method to Modify a Drug Delivery Device
5y 3m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
86%
With Interview (+27.4%)
3y 10m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 742 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month